retatrutide triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Today, we shared new data

If someone gets pregnant while taking a GLP-1 drug, they need to talk to their doctor as soon as possible

The compounds have been found in dietary supplements and products marked as "research only", creating exposure risk for athletes who may purchase such products for cognitive benefits without understanding they're consuming prohibited substances with no established safety profile

Camp-mediated signaling promotes the mTOR pathway in beta cells, which induces HIF-1 translational activation

The Phase 2 trial tested doses ranging from 0.5mg to 12mg

Questions and answers: withdrawal of marketing authorisation application for Egrifta (tesamorelin)

Some people experience unpleasant side effects (e.g., nausea, constipation) that do not resolve over time, preventing its continued use